Erythrodermic Psoriasis: Clinical Trials

1 trial for Erythrodermic Psoriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Erythrodermic Psoriasis: new trials by email Literature Review of Erythrodermic Psoriasis trials Research Report on Erythrodermic Psoriasis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis
Ixekizumab - Generalized Pustular Psoriasis, Erythrodermic Psoriasis
Phase 4CompletedEli Lilly and Company122019-07-052021-08-13

Narrower conditions

Psoriasis (1)

Broader conditions

Skin Diseases (1)  ·  Skin Diseases, Papulosquamous (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

ixekizumab (1)

Sponsors

Eli Lilly and Company (1)

Countries

Japan (1)

Results publications

PMID 34967916